Elevance Health (ELV) Short-term Investments (2009 - 2026)

Elevance Health (ELV) has reported Short-term Investments for 18 consecutive years, with $25.7 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Short-term Investments rose 2653.64% year-over-year to $25.7 billion; the TTM figure through Jun 2026 stood at $25.7 billion (up 2653.64% YoY), while the FY2025 annual figure was $740.0 million, down 37.92% from the prior year.
• Short-term Investments declined to $25.7 billion in Q2 2026 per ELV's latest filing, from $25.9 billion in the prior quarter.
• Across five years, Short-term Investments topped out at $26.3 billion in Q3 2025 and bottomed at $165.0 million in Q3 2023.
• Historically, Short-term Investments has averaged $5.0 billion across 5 years, with a median of $943.5 million in 2022.
• Annual changes were most pronounced in 2022 — Short-term Investments plunged 96.37% — and 2026, when it surged 3523.08%.
• Elevance Health's Short-term Investments stood at $953.0 million in 2022, then tumbled by 75.97% to $229.0 million in 2023, then soared by 420.52% to $1.2 billion in 2024, then tumbled by 37.92% to $740.0 million in 2025, then surged by 3375.54% to $25.7 billion in 2026.
• Business Quant data shows ELV's Short-term Investments at $25.7 billion in Q2 2026, $25.9 billion in Q1 2026, and $740.0 million in Q4 2025.